“PD-1 Inhibitors in Recurrent or Metastatic Oral Squamous Cell Carcinoma: Clinical Evidence, Patient Selection, and Immune-Related Toxicities”. 2026. Journal of Oral Health and Dental Therapeutics 1 (1): 27-31. https://doi.org/10.68041/johdt.v1i1/06.